REPORTS

Let’s Pullulate and Expand Your Business

Pharmaceutical Grade Marijuana Market - Global Professional Analysis and Forecast to 2026

Oct 17, 2019  |  180 PAGES  |  REPORT CODE: CMM214297
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Pharmaceutical Grade Marijuana market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.

This report presents the market size and development trends by detailing the Pharmaceutical Grade Marijuana market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pharmaceutical Grade Marijuana market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pharmaceutical Grade Marijuana industry and will help you to build a panoramic view of the industrial development.

Pharmaceutical Grade Marijuana Market, By Type:

  • Sativex

  • Cesamet

  • Marinol

  • Dexanabinol

  • Cannabinor

  • Others

Pharmaceutical Grade Marijuana Market, By Application:

  • Research & Academic Laboratories

  • Pharmaceutical & Biotechnology Companies

  • Hospitals

Some of the leading players are as follows:

  • Medical Marijuana Inc

  • Solvay Pharmaceuticals

  • Unimed Pharmaceuticals

  • GW Pharmaceuticals

  • Valeant Pharmaceuticals International

  • Teva Pharmaceutical

  • Merck

  • Sanofi-Aventis

  • Pharmos

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Pharmaceutical Grade Marijuana Market: Technology Type Analysis

  • 4.1 Pharmaceutical Grade Marijuana Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Pharmaceutical Grade Marijuana Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Sativex

    • 4.3.2 Cesamet

    • 4.3.3 Marinol

    • 4.3.4 Dexanabinol

    • 4.3.5 Cannabinor

    • 4.3.6 Others

5 Pharmaceutical Grade Marijuana Market: Product Analysis

  • 5.1 Pharmaceutical Grade Marijuana Product Market Share Analysis, 2018 & 2026

  • 5.2 Pharmaceutical Grade Marijuana Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Pharmaceutical Grade Marijuana Market: Application Analysis

  • 6.1 Pharmaceutical Grade Marijuana Application Market Share Analysis, 2018 & 2026

  • 6.2 Pharmaceutical Grade Marijuana Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Research & Academic Laboratories

    • 6.3.2 Pharmaceutical & Biotechnology Companies

    • 6.3.3 Hospitals

7 Pharmaceutical Grade Marijuana Market: Regional Analysis

  • 7.1 Pharmaceutical Grade Marijuana Regional Market Share Analysis, 2018 & 2026

  • 7.2 Pharmaceutical Grade Marijuana Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Medical Marijuana Inc

    • 9.1.1 Medical Marijuana Inc Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Solvay Pharmaceuticals

    • 9.2.1 Solvay Pharmaceuticals Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Unimed Pharmaceuticals

    • 9.3.1 Unimed Pharmaceuticals Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 GW Pharmaceuticals

    • 9.4.1 GW Pharmaceuticals Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Valeant Pharmaceuticals International

    • 9.5.1 Valeant Pharmaceuticals International Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Teva Pharmaceutical

    • 9.6.1 Teva Pharmaceutical Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Merck

    • 9.7.1 Merck Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Sanofi-Aventis

    • 9.8.1 Sanofi-Aventis Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Pharmos

    • 9.9.1 Pharmos Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

 

The List of Tables and Figures (Totals 103 Figures and 131 Tables)

  • Figure Sativex Pharmaceutical Grade Marijuana market, 2015 - 2026 (USD Million)

  • Figure Cesamet Pharmaceutical Grade Marijuana market, 2015 - 2026 (USD Million)

  • Figure Marinol Pharmaceutical Grade Marijuana market, 2015 - 2026 (USD Million)

  • Figure Dexanabinol Pharmaceutical Grade Marijuana market, 2015 - 2026 (USD Million)

  • Figure Cannabinor Pharmaceutical Grade Marijuana market, 2015 - 2026 (USD Million)

  • Figure Others Pharmaceutical Grade Marijuana market, 2015 - 2026 (USD Million)

  • Figure Research & Academic Laboratories market, 2015 - 2026 (USD Million)

  • Figure Pharmaceutical & Biotechnology Companies market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Pharmaceutical Grade Marijuana market, by country, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Grade Marijuana market, by country, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Grade Marijuana market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Grade Marijuana market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Grade Marijuana market, by country, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Pharmaceutical Grade Marijuana market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Grade Marijuana market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Grade Marijuana market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Medical Marijuana Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Solvay Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Unimed Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GW Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Valeant Pharmaceuticals International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi-Aventis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pharmos Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top